Fox Run Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-32,287
Closed -$294K 1147
2025
Q2
$294K Sell
32,287
-14,078
-30% -$104K 0.05% 644
2025
Q1
$419K Buy
+46,365
New +$490K 0.06% 562
2018
Q2
Sell
-16,593
Closed -$258K 847
2018
Q1
$258K Buy
+16,593
New +$296K 0.06% 543
2017
Q4
Sell
-12,000
Closed -$350K 824
2017
Q3
$350K Sell
12,000
-25,900
-68% -$765K 0.1% 430
2017
Q2
$1.22M Buy
37,900
+29,700
+362% +$975K 0.42% 15
2017
Q1
$284K Buy
+8,200
New +$293K 0.12% 382
2016
Q4
Sell
-14,600
Closed -$507K 626
2016
Q3
$507K Buy
+14,600
New +$511K 0.3% 101
2016
Q2
Sell
-8,600
Closed -$348K 630
2016
Q1
$348K Buy
+8,600
New +$320K 0.23% 181

Other funds holding ACH

Fox Run Management's ACH Position: Q3 2025 in Review

Fox Run Management sold out of Accendra Health (ACH) in Q3 2025, closing a stake of 32,287 shares — an estimated $294K sold.

Fox Run Management first reported a position in ACH in Q1 2016 and held it in 8 quarters. The position peaked at $1.22M in Q2 2017. 202 funds tracked by Wall St. Rank hold ACH as of Q3 2025.

  • Fox Run Management reported no remaining Accendra Health position as of Q3 2025 after selling out during the quarter.
  • Fox Run Management sold 32,287 Accendra Health shares in Q3 2025, an estimated $294K.
  • Fox Run Management first reported a position in Accendra Health in Q1 2016 and held it in 8 quarters.
  • Fox Run Management's Accendra Health position peaked at $1.22M in Q2 2017.
  • 202 funds tracked by Wall St. Rank held Accendra Health as of Q3 2025.

Based on Fox Run Management's 13F filing for Q3 2025, filed 12 Nov 2025.